Get started
Author

Jun Nagamine

Observed names: J Nagamine, J. Nagamine, Jun NAGAMINE
OpenAlex ID: A5066006520
Oxindole Derivatives as Orally Active Potent Growth Hormone Secretagogues
2001 · Teruhisa Tokunaga, W. Ewan Hume, et al. · Journal of Medicinal Chemistry · 287
Structure–activity relationships of the oxindole growth hormone secretagogues
2005 · Teruhisa Tokunaga, W. Ewan Hume, et al. · Bioorganic & Medicinal Chemistry Letters · 137
Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686
2001 · J Nagamine, R Nagata, et al. · Journal of Endocrinology · 61
PDF
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabeticdb/dbmice
2005 · Eiji Sugaru, Tsutomu Nakagawa, et al. · American Journal of Physiology-Renal Physiology · 27
Amelioration of Established Diabetic Nephropathy by Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in db/db Mice
2006 · Eiji Sugaru, Tsutomu Nakagawa, et al. · Nephron Experimental Nephrology · 16
Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy
2006 · Eiji Sugaru, Tsutomu Nakagawa, et al. · American Journal of Nephrology · 16
Effects of DSP-8658, a Novel Selective Peroxisome Proliferator-activated Receptors a/γ Modulator, on Adipogenesis and Glucose Metabolism in Diabetic Obese Mice
2015 · T. Goto, R. Nakayama, et al. · Experimental and Clinical Endocrinology & Diabetes · 12
Synthesis and Pharmacological Profile of an Orally-Active Growth Hormone Secretagogue, SM-130686
2006 · Jun Nagamine, Tetsuya Kawamura, et al. · Combinatorial Chemistry & High Throughput Screening · 10
Chronic Administration of SMP-534 Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats
2008 · Tsuyoshi Tsujimura, Jun Nagamine, et al. · Nephron Experimental Nephrology · 4
Recombinant human growth hormone (SMP-140) is effective for growth promotion in hypophysectomized rats
2006 · Jun NAGAMINE, Tsutomu NAKAGAWA, et al. · Biomedical Research · 4
PDF
Development of a new class of benzoylpyrrole-based PPARα/γ activators
2010 · Kantaro Ushiroda, Katsunori Maruta, et al. · Bioorganic & Medicinal Chemistry Letters · 3
Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats
2009 · Tsuyoshi Tsujimura, Jun Nagamine, et al. · Biological and Pharmaceutical Bulletin · 3
PDF
Pharmacological profile and clinical efficacy of imeglimin hydrochloride (TWYMEEG®Tablets), the orally drug for type 2 diabetes mellitus with the first dual mode of action in the world
2023 · Jun Nagamine · Folia Pharmacologica Japonica · 2
PDF
Author Index Vol. 110, 2008
2008 · Tsuyoshi Tsujimura, Jun Nagamine, et al. · Nephron Experimental Nephrology · 2
PDF
Structure—Activity Relationships of the Oxindole Growth Hormone Secretagogues.
2005 · Teruhisa Tokunaga, W. Ewan Hume, et al. · ChemInform · 2
The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters
2009 · Tsuyoshi Tsujimura, Michiko Ono-Kishino, et al. · Biomedical Research · 1
PDF
Wcn26-4487 Renoprotective Effects of Imeglimin in a Model of Acute Kidney Injury
2026 · Hiroki Muramatsu, Naoto Yoshida, et al. · Kidney International Reports
PDF
ChemInform Abstract: Development of a New Class of Benzoylpyrrole‐Based PPARα/γ Activators.
2011 · Kantaro Ushiroda, Katsunori Maruta, et al. · ChemInform
Subject Index Vol. 110, 2008
2008 · Tsuyoshi Tsujimura, Jun Nagamine, et al. · Nephron Experimental Nephrology
Works count: 19
Citation count: 587
H-index: 8
I10-index: 8
Year
Topic
Type